Click here to get full coverage on MODD, LAB, HOWL, COGT, LGVN, ABCL Lead Biotech After-Hours Rally - Nov 26 - Nasdaq

MODD, LAB, HOWL, COGT, LGVN, ABCL Lead Biotech After-Hours Rally - Nov 26  Nasdaq

MODD, LAB, HOWL, COGT, LGVN, ABCL Lead Biotech After-Hours Rally - Nov 26 - Nasdaq

Click here to get full coverage on Cogent Biosciences (COGT): Evaluating Valuation After Positive Phase 3 Cancer Trial Results and New Drug Plans - Yahoo Finance

Cogent Biosciences (COGT): Evaluating Valuation After Positive Phase 3 Cancer Trial Results and New Drug Plans  Yahoo Finance

Cogent Biosciences (COGT): Evaluating Valuation After Positive Phase 3 Cancer Trial Results and New Drug Plans - Yahoo Finance

Click here to get full coverage on A Look at Cogent Biosciences (COGT) Valuation Following Positive Phase 3 Trial Results - simplywall.st

A Look at Cogent Biosciences (COGT) Valuation Following Positive Phase 3 Trial Results  simplywall.st

A Look at Cogent Biosciences (COGT) Valuation Following Positive Phase 3 Trial Results - simplywall.st

Click here to get full coverage on Why Cogent Biosciences (COGT) Is Up 18.9% After Positive Phase 3 GIST Trial Results - Sahm

Why Cogent Biosciences (COGT) Is Up 18.9% After Positive Phase 3 GIST Trial Results  Sahm

Why Cogent Biosciences (COGT) Is Up 18.9% After Positive Phase 3 GIST Trial Results - Sahm

Click here to get full coverage on Why Is Cogent Biosciences Stock (COGT) Up 115% Today? - TipRanks

Why Is Cogent Biosciences Stock (COGT) Up 115% Today?  TipRanks

Why Is Cogent Biosciences Stock (COGT) Up 115% Today? - TipRanks

Click here to get full coverage on Cogent Bio surges on trial data for lead drug (COGT:NASDAQ) - Seeking Alpha

Cogent Bio surges on trial data for lead drug (COGT:NASDAQ)  Seeking Alpha

Cogent Bio surges on trial data for lead drug (COGT:NASDAQ) - Seeking Alpha

Click here to get full coverage on COGENT BIOSCIENCES Earnings Preview: Recent $COGT Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative

COGENT BIOSCIENCES Earnings Preview: Recent $COGT Insider Trading, Hedge Fund Activity, and More  Quiver Quantitative

COGENT BIOSCIENCES Earnings Preview: Recent $COGT Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative

Click here to get full coverage on Will Cogent Biosciences’ (COGT) Breakthrough Therapy Transform GIST Treatment? Analysts Think So - Yahoo Finance

Will Cogent Biosciences’ (COGT) Breakthrough Therapy Transform GIST Treatment? Analysts Think So  Yahoo Finance

Will Cogent Biosciences’ (COGT) Breakthrough Therapy Transform GIST Treatment? Analysts Think So - Yahoo Finance

Click here to get full coverage on COGT Stock Skyrockets 120% in a Month: Here's What You Need to Know - Zacks Investment Research

COGT Stock Skyrockets 120% in a Month: Here's What You Need to Know  Zacks Investment Research

COGT Stock Skyrockets 120% in a Month: Here's What You Need to Know - Zacks Investment Research

Click here to get full coverage on Leerink Partners Maintains Cogent Biosciences (COGT) Outperform Recommendation - Nasdaq

Leerink Partners Maintains Cogent Biosciences (COGT) Outperform Recommendation  Nasdaq

Leerink Partners Maintains Cogent Biosciences (COGT) Outperform Recommendation - Nasdaq

Click here to get full coverage on Cogent Biosciences (COGT) Climbs to New Record High on Cancer Treatment Drug Trial - Yahoo Finance

Cogent Biosciences (COGT) Climbs to New Record High on Cancer Treatment Drug Trial  Yahoo Finance

Cogent Biosciences (COGT) Climbs to New Record High on Cancer Treatment Drug Trial - Yahoo Finance

Click here to get full coverage on Cogent Biosciences (COGT) Soars 126% on Stomach Cancer Treatment Progress - Yahoo Finance

Cogent Biosciences (COGT) Soars 126% on Stomach Cancer Treatment Progress  Yahoo Finance

Cogent Biosciences (COGT) Soars 126% on Stomach Cancer Treatment Progress - Yahoo Finance

Click here to get full coverage on Cogent Biosciences (COGT) Is Up 144.5% After Bezuclastinib Phase 3 Win and $500M Capital Raise Has The Bull Case Changed? - Yahoo Finance

Cogent Biosciences (COGT) Is Up 144.5% After Bezuclastinib Phase 3 Win and $500M Capital Raise Has The Bull Case Changed?  Yahoo Finance

Cogent Biosciences (COGT) Is Up 144.5% After Bezuclastinib Phase 3 Win and $500M Capital Raise Has The Bull Case Changed? - Yahoo Finance

Click here to get full coverage on Cogent Biosciences Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2031 and Common Stock - Yahoo Finance

Cogent Biosciences Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2031 and Common Stock  Yahoo Finance

Cogent Biosciences Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2031 and Common Stock - Yahoo Finance

Click here to get full coverage on Cogent Biosciences (COGT): Assessing Valuation After a 94% Year-to-Date Share Price Surge - Yahoo Finance

Cogent Biosciences (COGT): Assessing Valuation After a 94% Year-to-Date Share Price Surge  Yahoo Finance

Cogent Biosciences (COGT): Assessing Valuation After a 94% Year-to-Date Share Price Surge - Yahoo Finance

Click here to get full coverage on Cogent Biosciences (NASDAQ: COGT) expects Phase 3 PEAK Nov and APEX Dec readouts - Stock Titan

Cogent Biosciences (NASDAQ: COGT) expects Phase 3 PEAK Nov and APEX Dec readouts  Stock Titan

Cogent Biosciences (NASDAQ: COGT) expects Phase 3 PEAK Nov and APEX Dec readouts - Stock Titan

Click here to get full coverage on Cogent Biosciences, Inc. (NASDAQ:COGT) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Cogent Biosciences, Inc. (NASDAQ:COGT) Given Consensus Recommendation of "Moderate Buy" by Brokerages  MarketBeat

Cogent Biosciences, Inc. (NASDAQ:COGT) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Click here to get full coverage on Jefferies Raises Cogent Biosciences (COGT) PT, Keeps Buy Rating - Yahoo Finance

Jefferies Raises Cogent Biosciences (COGT) PT, Keeps Buy Rating  Yahoo Finance

Jefferies Raises Cogent Biosciences (COGT) PT, Keeps Buy Rating - Yahoo Finance

Click here to get full coverage on Cogent (Nasdaq: COGT) commences $200M convertible notes due 2031 and stock offering - Stock Titan

Cogent (Nasdaq: COGT) commences $200M convertible notes due 2031 and stock offering  Stock Titan

Cogent (Nasdaq: COGT) commences $200M convertible notes due 2031 and stock offering - Stock Titan

Click here to get full coverage on Cogent Biosciences: Soaring On Blowout GIST Data - I Expect More Upside (NASDAQ:COGT) - Seeking Alpha

Cogent Biosciences: Soaring On Blowout GIST Data - I Expect More Upside (NASDAQ:COGT)  Seeking Alpha

Cogent Biosciences: Soaring On Blowout GIST Data - I Expect More Upside (NASDAQ:COGT) - Seeking Alpha

Click here to get full coverage on 299,200 Stock Options: Cogent Biosciences Strengthens Team with 10 New Hires and Equity Incentives - Stock Titan

299,200 Stock Options: Cogent Biosciences Strengthens Team with 10 New Hires and Equity Incentives  Stock Titan

299,200 Stock Options: Cogent Biosciences Strengthens Team with 10 New Hires and Equity Incentives - Stock Titan

Click here to get full coverage on COGT Stock Soars on Phase III Systemic Mastocytosis Study Success - Zacks Investment Research

COGT Stock Soars on Phase III Systemic Mastocytosis Study Success  Zacks Investment Research

COGT Stock Soars on Phase III Systemic Mastocytosis Study Success - Zacks Investment Research

Click here to get full coverage on Cogent Biosciences (NASDAQ: COGT) prices 9,677,420 shares at $31; plus convertible notes - Stock Titan

Cogent Biosciences (NASDAQ: COGT) prices 9,677,420 shares at $31; plus convertible notes  Stock Titan

Cogent Biosciences (NASDAQ: COGT) prices 9,677,420 shares at $31; plus convertible notes - Stock Titan

Click here to get full coverage on HC Wainwright & Co. Reiterates Cogent Biosciences (COGT) Buy Recommendation - Nasdaq

HC Wainwright & Co. Reiterates Cogent Biosciences (COGT) Buy Recommendation  Nasdaq

HC Wainwright & Co. Reiterates Cogent Biosciences (COGT) Buy Recommendation - Nasdaq

Click here to get full coverage on HC Wainwright Issues Negative Forecast for COGT Earnings - MarketBeat

HC Wainwright Issues Negative Forecast for COGT Earnings  MarketBeat

HC Wainwright Issues Negative Forecast for COGT Earnings - MarketBeat

Click here to get full coverage on Cogent Biosciences Inc. (COGT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Cogent Biosciences Inc. (COGT) Stock Price | Live Quotes & Charts | NASDAQ  StocksToTrade

Cogent Biosciences Inc. (COGT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Click here to get full coverage on Biggest stock movers Monday: RUM, MTSR, COGT, OSCR, and more - Seeking Alpha

Biggest stock movers Monday: RUM, MTSR, COGT, OSCR, and more  Seeking Alpha

Biggest stock movers Monday: RUM, MTSR, COGT, OSCR, and more - Seeking Alpha

Click here to get full coverage on Day 5 of Gains Streak for Cogent Biosciences Stock with 137% Return (vs. 328% YTD) [11/11/2025] - Trefis

Day 5 of Gains Streak for Cogent Biosciences Stock with 137% Return (vs. 328% YTD) [11/11/2025]  Trefis

Day 5 of Gains Streak for Cogent Biosciences Stock with 137% Return (vs. 328% YTD) [11/11/2025] - Trefis

Click here to get full coverage on Cogent Bio (NASDAQ: COGT) to present NonAdvSM bezuclastinib, JAK2 V617F poster at ASH - Stock Titan

Cogent Bio (NASDAQ: COGT) to present NonAdvSM bezuclastinib, JAK2 V617F poster at ASH  Stock Titan

Cogent Bio (NASDAQ: COGT) to present NonAdvSM bezuclastinib, JAK2 V617F poster at ASH - Stock Titan

Click here to get full coverage on Is Cogent Biosciences, Inc. (COGT) the Best Small Cap Stock to Buy with the Biggest Upside Potential? - Yahoo Finance

Is Cogent Biosciences, Inc. (COGT) the Best Small Cap Stock to Buy with the Biggest Upside Potential?  Yahoo Finance

Is Cogent Biosciences, Inc. (COGT) the Best Small Cap Stock to Buy with the Biggest Upside Potential? - Yahoo Finance

Click here to get full coverage on Cogent Biosciences Shares Surge 135% After Strong Cancer Drug Trial Results - Nasdaq

Cogent Biosciences Shares Surge 135% After Strong Cancer Drug Trial Results  Nasdaq

Cogent Biosciences Shares Surge 135% After Strong Cancer Drug Trial Results - Nasdaq

Click here to get full coverage on Cogent Biosciences: Moving Forward (NASDAQ:COGT) - Seeking Alpha

Cogent Biosciences: Moving Forward (NASDAQ:COGT)  Seeking Alpha

Cogent Biosciences: Moving Forward (NASDAQ:COGT) - Seeking Alpha

Click here to get full coverage on Assessing Cogent Biosciences (COGT) Valuation After Strong Recent Share Price Surge - simplywall.st

Assessing Cogent Biosciences (COGT) Valuation After Strong Recent Share Price Surge  simplywall.st

Assessing Cogent Biosciences (COGT) Valuation After Strong Recent Share Price Surge - simplywall.st

Click here to get full coverage on Cogent: Another Win For Bezuclastinib In GIST Warrants Continued Strong Buy (COGT) - Seeking Alpha

Cogent: Another Win For Bezuclastinib In GIST Warrants Continued Strong Buy (COGT)  Seeking Alpha

Cogent: Another Win For Bezuclastinib In GIST Warrants Continued Strong Buy (COGT) - Seeking Alpha

Click here to get full coverage on Biotech Catapults 119% On A First-In-20-Years Development - Investor's Business Daily

Biotech Catapults 119% On A First-In-20-Years Development  Investor's Business Daily

Biotech Catapults 119% On A First-In-20-Years Development - Investor's Business Daily

Click here to get full coverage on New Analyst Forecast: $COGT Given $50.0 Price Target - Quiver Quantitative

New Analyst Forecast: $COGT Given $50.0 Price Target  Quiver Quantitative

New Analyst Forecast: $COGT Given $50.0 Price Target - Quiver Quantitative

Click here to get full coverage on Positive Phase 3 Results and $500 Million Raise Might Change the Case for Investing in Cogent Biosciences (COGT) - Sahm

Positive Phase 3 Results and $500 Million Raise Might Change the Case for Investing in Cogent Biosciences (COGT)  Sahm

Positive Phase 3 Results and $500 Million Raise Might Change the Case for Investing in Cogent Biosciences (COGT) - Sahm

Click here to get full coverage on Why Is Cogent Biosciences Stock Trading Higher Today? - Cogent Biosciences (NASDAQ:COGT) - Benzinga

Why Is Cogent Biosciences Stock Trading Higher Today? - Cogent Biosciences (NASDAQ:COGT)  Benzinga

Why Is Cogent Biosciences Stock Trading Higher Today? - Cogent Biosciences (NASDAQ:COGT) - Benzinga

Click here to get full coverage on Breakthrough Therapy Designation: Cogent's bezuclastinib gains FDA nod, NDA submission planned by YE 2025 - Stock Titan

Breakthrough Therapy Designation: Cogent's bezuclastinib gains FDA nod, NDA submission planned by YE 2025  Stock Titan

Breakthrough Therapy Designation: Cogent's bezuclastinib gains FDA nod, NDA submission planned by YE 2025 - Stock Titan

Click here to get full coverage on Precision Medicine Biotech Cogent Biosciences to Present Latest Developments at Major Biopharma Conference - Stock Titan

Precision Medicine Biotech Cogent Biosciences to Present Latest Developments at Major Biopharma Conference  Stock Titan

Precision Medicine Biotech Cogent Biosciences to Present Latest Developments at Major Biopharma Conference - Stock Titan

Click here to get full coverage on Cogent Biosciences' (COGT) Buy Rating Reiterated at HC Wainwright - MarketBeat

Cogent Biosciences' (COGT) Buy Rating Reiterated at HC Wainwright  MarketBeat

Cogent Biosciences' (COGT) Buy Rating Reiterated at HC Wainwright - MarketBeat

Click here to get full coverage on 427,342 Shares in Cogent Biosciences, Inc. $COGT Purchased by Candriam S.C.A. - MarketBeat

427,342 Shares in Cogent Biosciences, Inc. $COGT Purchased by Candriam S.C.A.  MarketBeat

427,342 Shares in Cogent Biosciences, Inc. $COGT Purchased by Candriam S.C.A. - MarketBeat

Click here to get full coverage on Cogent Biosciences (COGT) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat

Cogent Biosciences (COGT) Expected to Announce Quarterly Earnings on Tuesday  MarketBeat

Cogent Biosciences (COGT) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat

Click here to get full coverage on Profund Advisors LLC Has $145,000 Stock Holdings in Cogent Biosciences, Inc. $COGT - MarketBeat

Profund Advisors LLC Has $145,000 Stock Holdings in Cogent Biosciences, Inc. $COGT  MarketBeat

Profund Advisors LLC Has $145,000 Stock Holdings in Cogent Biosciences, Inc. $COGT - MarketBeat

Click here to get full coverage on Why Cogent Biosciences (COGT) Is One of the Best Low Priced Biotech Stocks to Buy Now - Yahoo Finance

Why Cogent Biosciences (COGT) Is One of the Best Low Priced Biotech Stocks to Buy Now  Yahoo Finance

Why Cogent Biosciences (COGT) Is One of the Best Low Priced Biotech Stocks to Buy Now - Yahoo Finance

Click here to get full coverage on Insider Purchase: Director at $COGT Buys 2,777,777 Shares - Quiver Quantitative

Insider Purchase: Director at $COGT Buys 2,777,777 Shares  Quiver Quantitative

Insider Purchase: Director at $COGT Buys 2,777,777 Shares - Quiver Quantitative

Click here to get full coverage on COGT Crosses Above Average Analyst Target - Nasdaq

COGT Crosses Above Average Analyst Target  Nasdaq

COGT Crosses Above Average Analyst Target - Nasdaq

Click here to get full coverage on Fox Run Management L.L.C. Trims Stock Position in Cogent Biosciences, Inc. $COGT - MarketBeat

Fox Run Management L.L.C. Trims Stock Position in Cogent Biosciences, Inc. $COGT  MarketBeat

Fox Run Management L.L.C. Trims Stock Position in Cogent Biosciences, Inc. $COGT - MarketBeat

Click here to get full coverage on COGT Stock Skyrockets 120% in a Month: Here's What You Need to Know - sharewise.com

COGT Stock Skyrockets 120% in a Month: Here's What You Need to Know  sharewise.com

COGT Stock Skyrockets 120% in a Month: Here's What You Need to Know - sharewise.com

Click here to get full coverage on Cogent Biosciences (NASDAQ:COGT) Sets New 12-Month High - Still a Buy? - MarketBeat

Cogent Biosciences (NASDAQ:COGT) Sets New 12-Month High - Still a Buy?  MarketBeat

Cogent Biosciences (NASDAQ:COGT) Sets New 12-Month High - Still a Buy? - MarketBeat

Click here to get full coverage on Cogent Biosciences (NASDAQ:COGT) Shares Gap Down - What's Next? - MarketBeat

Cogent Biosciences (NASDAQ:COGT) Shares Gap Down - What's Next?  MarketBeat

Cogent Biosciences (NASDAQ:COGT) Shares Gap Down - What's Next? - MarketBeat

Click here to get full coverage on New Analyst Forecast: $COGT Given $22.0 Price Target - Nasdaq

New Analyst Forecast: $COGT Given $22.0 Price Target  Nasdaq

New Analyst Forecast: $COGT Given $22.0 Price Target - Nasdaq

Click here to get full coverage on Cogent Biosciences (COGT) Launches $400M Public Offerings - GuruFocus

Cogent Biosciences (COGT) Launches $400M Public Offerings  GuruFocus

Cogent Biosciences (COGT) Launches $400M Public Offerings - GuruFocus

Click here to get full coverage on Baird Maintains Cogent Biosciences(COGT.US) With Hold Rating, Raises Target Price to $34 - 富途牛牛

Baird Maintains Cogent Biosciences(COGT.US) With Hold Rating, Raises Target Price to $34  富途牛牛

Baird Maintains Cogent Biosciences(COGT.US) With Hold Rating, Raises Target Price to $34 - 富途牛牛

Click here to get full coverage on Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2025 Financial Results - Investing News Network

Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2025 Financial Results  Investing News Network

Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2025 Financial Results - Investing News Network

Click here to get full coverage on Biotech Star Cogent Rides High On Breakthrough Trial Hopes - Finimize

Biotech Star Cogent Rides High On Breakthrough Trial Hopes  Finimize

Biotech Star Cogent Rides High On Breakthrough Trial Hopes - Finimize

Click here to get full coverage on $COGT stock is up 9% today. Here's what we see in our data. - Quiver Quantitative

$COGT stock is up 9% today. Here's what we see in our data.  Quiver Quantitative

$COGT stock is up 9% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Cogent Biosciences launches $400 mln equity, convertible deals after stock more than doubles - TradingView

Cogent Biosciences launches $400 mln equity, convertible deals after stock more than doubles  TradingView

Cogent Biosciences launches $400 mln equity, convertible deals after stock more than doubles - TradingView

Click here to get full coverage on Cogent Biosciences (NASDAQ:COGT) Price Target Raised to $34.00 - MarketBeat

Cogent Biosciences (NASDAQ:COGT) Price Target Raised to $34.00  MarketBeat

Cogent Biosciences (NASDAQ:COGT) Price Target Raised to $34.00 - MarketBeat

Click here to get full coverage on Cogent Biosciences (NASDAQ:COGT) Price Target Raised to $50.00 at Leerink Partners - MarketBeat

Cogent Biosciences (NASDAQ:COGT) Price Target Raised to $50.00 at Leerink Partners  MarketBeat

Cogent Biosciences (NASDAQ:COGT) Price Target Raised to $50.00 at Leerink Partners - MarketBeat

Click here to get full coverage on FY2025 Earnings Estimate for COGT Issued By HC Wainwright - MarketBeat

FY2025 Earnings Estimate for COGT Issued By HC Wainwright  MarketBeat

FY2025 Earnings Estimate for COGT Issued By HC Wainwright - MarketBeat

Click here to get full coverage on Cogent Biosciences (COGT) Boosts Stock Offering to $300 Million - GuruFocus

Cogent Biosciences (COGT) Boosts Stock Offering to $300 Million  GuruFocus

Cogent Biosciences (COGT) Boosts Stock Offering to $300 Million - GuruFocus

Click here to get full coverage on Cogent Biosciences (COGT) Shares Skyrocket Over 100% - GuruFocus

Cogent Biosciences (COGT) Shares Skyrocket Over 100%  GuruFocus

Cogent Biosciences (COGT) Shares Skyrocket Over 100% - GuruFocus

Click here to get full coverage on Cogent Biosciences Raises $150M in Stock Offering to Advance Precision Therapy Commercialization - Stock Titan

Cogent Biosciences Raises $150M in Stock Offering to Advance Precision Therapy Commercialization  Stock Titan

Cogent Biosciences Raises $150M in Stock Offering to Advance Precision Therapy Commercialization - Stock Titan

Click here to get full coverage on Cogent Biosciences (COGT): Among the Most Promising Penny Stocks According to Analysts - Yahoo Finance

Cogent Biosciences (COGT): Among the Most Promising Penny Stocks According to Analysts  Yahoo Finance

Cogent Biosciences (COGT): Among the Most Promising Penny Stocks According to Analysts - Yahoo Finance

Click here to get full coverage on Cogent Biosciences stock soars after positive Phase 3 cancer drug results - Investing.com

Cogent Biosciences stock soars after positive Phase 3 cancer drug results  Investing.com

Cogent Biosciences stock soars after positive Phase 3 cancer drug results - Investing.com

Click here to get full coverage on Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Cogent Biosciences (COGT) - The Globe and Mail

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Cogent Biosciences (COGT)  The Globe and Mail

COGT

Price Chart

Key Statistics

Technicals

About COGT

Latest News

MODD, LAB, HOWL, COGT, LGVN, ABCL Lead Biotech After-Hours Rally - Nov 26 - Nasdaq

Cogent Biosciences (COGT): Evaluating Valuation After Positive Phase 3 Cancer Trial Results and New Drug Plans - Yahoo Finance

A Look at Cogent Biosciences (COGT) Valuation Following Positive Phase 3 Trial Results - simplywall.st

Advanced Charts

Top Gainers

Top Losers